| Pre-analytical Factor | Classification | Bodily fluids | Cells/Tissue | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Blood | Serum | Plasma | Urine | Saliva | |||||||
| Data handling | Platform Specific Methodology - Next generation sequencing | 4 | 0 | 3 | 0 | 0 | 9 | ||||
| Length of gene fragment | Platform Specific Methodology - Next generation sequencing | 0 | 0 | 0 | 0 | 0 | 2 | ||||
| Nucleic acid amplification | Platform Specific Methodology - Next generation sequencing | 2 | 0 | 1 | 0 | 0 | 4 | ||||
| Priming method | Platform Specific Methodology - Next generation sequencing | 0 | 0 | 1 | 0 | 0 | 1 | ||||
| Reaction solution | Platform Specific Methodology - Next generation sequencing | 0 | 0 | 0 | 0 | 0 | 2 | ||||
| Targeted nucleic acid | Platform Specific Methodology - Next generation sequencing | 2 | 0 | 6 | 0 | 0 | 8 | ||||
| Technology platform | Platform Specific Methodology - Next generation sequencing | 5 | 1 | 19 | 2 | 1 | 47 | ||||
| Template modification | Platform Specific Methodology - Next generation sequencing | 2 | 0 | 3 | 0 | 0 | 18 | ||||
| Template/input amount | Platform Specific Methodology - Next generation sequencing | 5 | 1 | 6 | 0 | 0 | 17 | ||||
| Type of tissue stain | Platform Specific Methodology - Next generation sequencing | 0 | 0 | 0 | 0 | 0 | 3 | ||||